Generative AI Policy
IDJBT acknowledges the increasing use of generative artificial intelligence (AI) and large language model (LLM) tools in academic research and writing. This policy establishes the journal's position on the acceptable use of such tools, in alignment with guidelines from the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
Generative AI tools — including but not limited to ChatGPT, Claude, Gemini, Copilot, and similar large language models — may not be listed as authors of any manuscript submitted to or published in IDJBT. This position is consistent with ICMJE authorship criteria, which require that authors:
AI tools cannot fulfill any of these criteria. Responsibility for all AI-assisted content lies entirely with the human authors.
Authors may use AI tools for the following purposes, provided the use is disclosed:
Authors who use AI tools in any substantive capacity must disclose this use in the Methods section (for AI used in research processes) or the Acknowledgements section (for AI used in manuscript preparation). The disclosure must include:
Example Disclosure Statement:
"ChatGPT-4o (OpenAI) was used to assist with language editing and grammar correction of this manuscript. The authors reviewed all AI-assisted text and take full responsibility for the accuracy and integrity of the content."
This policy is grounded in current guidance from ICMJE (Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals) and COPE (Position Statement on Authorship and AI Tools). IDJBT reserves the right to update this policy as international standards evolve. Any violations of this policy will be treated in accordance with COPE's guidelines for handling misconduct.
Questions: editorial@idjbt.id